Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study

Omega-3 Fatty Acids in the Prevention of Interferon-Alpha-Induced Depression: Results from a Randomized, Controlled Trial

(2014) Kuan-Pin Su et al.   BIOLOGICAL PSYCHIATRY

Role of C Reactive Protein (CRP) in Leptin Resistance

(2014) Marta Hribal et al.   CURRENT PHARMACEUTICAL DESIGN

Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects

(2014) Ole Köhler et al.   JAMA Psychiatry

Adiponectin in inflammatory and immune-mediated diseases

(2013) Giamila Fantuzzi   CYTOKINE

Conceptual Confluence: The Kynurenine Pathway as a Common Target for Ketamine and the Convergence of the Inflammation and Glutamate Hypotheses of Depression

(2013) Andrew H Miller   NEUROPSYCHOPHARMACOLOGY

Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease

(2013) Clara M. Yates et al.   PHARMACOLOGY & THERAPEUTICS

Obesity and psychiatric disorders: Commonalities in dysregulated biological pathways and their implications for treatment

(2013) Adrian L. Lopresti et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Immunomodulation by dietary long chain omega-3 fatty acids and the potential for adverse health outcomes

(2013) Jenifer I. Fenton et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Long-chain omega 3 fatty acids: Molecular bases of potential antioxidant actions

(2013) Elena Giordano et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

(2012) Robert K McNamara et al.   Expert Review of Neurotherapeutics

Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events

(2012) Evangelos C. Rizos et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Evolutionary medicine and chronic inflammatory state—known and new concepts in pathophysiology

(2012) Rainer H. Straub   JOURNAL OF MOLECULAR MEDICINE-JMM

Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation and severity of depression

(2012) P-Y Lin et al.   MOLECULAR PSYCHIATRY

Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis

(2012) J G Martins et al.   MOLECULAR PSYCHIATRY

Adipocytokines, Hepatic and Inflammatory Biomarkers and Incidence of Type 2 Diabetes. The CoLaus Study

(2012) Pedro Marques-Vidal et al.   PLoS One

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression

(2012) Charles L. Raison et al.   JAMA Psychiatry

Trajectories of Depression Severity in Clinical Trials of Duloxetine

(2011) Ralitza Gueorguieva   ARCHIVES OF GENERAL PSYCHIATRY

Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression

(2011) M. Elizabeth Sublette et al.   JOURNAL OF CLINICAL PSYCHIATRY

Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder

(2011) Lev Gertsik et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?

(2011) Johann Steiner et al.   Journal of Neuroinflammation

Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis

(2011) M H Bloch et al.   MOLECULAR PSYCHIATRY

Functional Biomarkers of Depression: Diagnosis, Treatment and Pathophysiology

(2011) Heath D Schmidt et al.   NEUROPSYCHOPHARMACOLOGY

Immune system to brain signaling: Neuropsychopharmacological implications

(2011) Lucile Capuron et al.   PHARMACOLOGY & THERAPEUTICS

Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans

(2011) J. L. Warner-Schmidt et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Association Between Depression and Inflammation-Differences by Race and Sex

(2011) Alanna AMYRE Morris et al.   PSYCHOSOMATIC MEDICINE

Inflammatory Biomarkers in 70 Depressed Inpatients With and Without the Metabolic Syndrome

(2010) Sara Zeugmann et al.   JOURNAL OF CLINICAL PSYCHIATRY

The Efficacy of Omega-3 Supplementation for Major Depression

(2010) François Lespérance et al.   JOURNAL OF CLINICAL PSYCHIATRY

Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients

(2010) Michael Maes et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

(2009) Andrew H. Miller et al.   BIOLOGICAL PSYCHIATRY

Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis

(2009) M Bryant Howren et al.   PSYCHOSOMATIC MEDICINE

Comparison of Therapeutic Effects of Omega-3 Fatty Acid Eicosapentaenoic Acid and Fluoxetine, Separately and in Combination, in Major Depressive Disorder

(2008) Shima Jazayeri et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Depressive Symptoms and Metabolic Syndrome: Is Inflammation the Underlying Link?

(2008) Lucile Capuron et al.   BIOLOGICAL PSYCHIATRY

A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder

(2008) David Mischoulon et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Inflammatory Biomarkers and Risks of Myocardial Infarction, Stroke, Diabetes, and Total Mortality: Implications for Longevity

(2008) Paul M Ridker   NUTRITION REVIEWS